Cargando…
Evaluating ELISA, Immunofluorescence, and Lateral Flow Assay for SARS-CoV-2 Serologic Assays
BACKGROUND: The SARS-CoV-2 outbreak has emerged at the end of 2019. Aside from the detection of viral genome with specific RT-PCR, there is a growing need for reliable determination of the serological status. We aimed at evaluating five SARS-CoV-2 serology assays. METHODS: An in-house immunofluoresc...
Autores principales: | Michel, Moïse, Bouam, Amar, Edouard, Sophie, Fenollar, Florence, Di Pinto, Fabrizio, Mège, Jean-Louis, Drancourt, Michel, Vitte, Joana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7759487/ https://www.ncbi.nlm.nih.gov/pubmed/33362745 http://dx.doi.org/10.3389/fmicb.2020.597529 |
Ejemplares similares
-
Evaluating the serological status of COVID-19 patients using an indirect immunofluorescent assay, France
por: Edouard, S., et al.
Publicado: (2020) -
Immunofluorescence Assay for Serologic Diagnosis of SARS
por: Chan, Paul K. S., et al.
Publicado: (2004) -
Performance of an ELISA and Indirect Immunofluorescence Assay in Serological Diagnosis of Zoonotic Cutaneous Leishmaniasis in Iran
por: Sarkari, Bahador, et al.
Publicado: (2014) -
Determination of Cutoff of ELISA and Immunofluorescence Assay for Scrub Typhus
por: Gupta, Nitin, et al.
Publicado: (2016) -
Evaluation of a Multiparametric Immunofluorescence Assay for Standardization of Neuromyelitis Optica Serology
por: Granieri, Letizia, et al.
Publicado: (2012)